4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-025417
Director sold 1,155 shares at $84.89 ($98,045)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-09-14 | Sale | −1,155 | $84.89 | $98,045 | 530,190 | I: show line 1 in the form |
| Open-market sales · 1,155 sh · avg $84.89 · $98,045 | |||||||
Loading xslF345X03/doc4.xml…